Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts
- PMID: 3872316
- PMCID: PMC423634
- DOI: 10.1172/JCI111796
Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts
Abstract
1,25(OH)2D3 induces 25(OH)D3-24-hydroxylase (24-OHase) in cultured skin fibroblasts from normal subjects. We evaluated 24-OHase induction by 1,25(OH)2D3 in skin fibroblasts from 10 normal subjects and from four unrelated patients with hereditary resistance to 1,25(OH)2D or vitamin D-dependent rickets type II (DD II). Fibroblasts were preincubated with varying concentrations of 1,25(OH)2D3 for 15 h and were then incubated with 0.5 microM [3H]25(OH)D3 at 37 degrees C for 30 min; lipid extracts of the cells were analyzed for [3H]24,25(OH)2D3 by high performance liquid chromatography and periodate oxidation. Apparent maximal [3H]24,25(OH)2D3 production in normal cell lines was 9 pmol/10(6) cells per 30 min and occurred after induction with 10(-8) M 1,25(OH)2D3. 24-OHase induction was detectable in normal fibroblasts at approximately 3 X 10(-10) M 1,25(OH)2D3. [3H]24,25(OH)2D3 formation after exposure to 1,25(OH)2D3 was abnormal in fibroblasts from all four patients with DD II. In fibroblasts from two patients with DD II, [3H]24,25(OH)2D3 formation was unmeasurable (below 0.2 pmol/10(6) cells per 30 min) at 1,25(OH)2D3 concentrations up to 10(-6) M. Fibroblasts from the other two patients with DD II required far higher than normal concentrations of 1,25(OH)2D3 for detectable [3H]24,25(OH)2D3 induction. In one, [3H]24,25(OH)2D3 production reached 2.9 pmol/10(6) cells per 30 min at 10(-6) M 1,25(OH)2D3 (30% normal maximum at 10(-6) M 1,25(OH)2D3). In the other, [3H]24,25(OH)2D3 production achieved normal levels, 7.3 pmol/10(6) cells per 30 min after 10(-6) M 1,25(OH)2D3. The two patients whose cells had a detectable 24-OHase induction by 1,25(OH)2D3 showed a calcemic response to high doses of calciferols in vivo. Our current observations correlate with these two patients' responsiveness to calciferols in vivo and suggest that their target organ defects can be partially or completely overcome with extremely high concentrations of 1,25(OH)2D3. The two patients whose cells showed no detectable 24-OHase induction in vitro failed to show a calcemic response to high doses of calciferols in vivo.
In conclusion: (a) the measurement of 24-OHase induction by 1,25(OH)2D3 in cultured skin fibroblasts is a sensitive in vitro test for defective genes in the 1,25(OH)2D effector pathway. (b) This assay provides a useful tool for characterizing the target tissue defects in DD II and predicting response to calciferol therapy.
Similar articles
-
Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.J Clin Invest. 1983 Oct;72(4):1190-9. doi: 10.1172/JCI111074. J Clin Invest. 1983. PMID: 6313754 Free PMC article.
-
1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents.J Clin Endocrinol Metab. 1984 Sep;59(3):383-8. doi: 10.1210/jcem-59-3-383. J Clin Endocrinol Metab. 1984. PMID: 6086691
-
Expression of 25-hydroxyvitamin D3-24-hydroxylase activity in Caco-2 cells. An in vitro model of intestinal vitamin D catabolism.Endocrinology. 1990 Jun;126(6):2868-75. doi: 10.1210/endo-126-6-2868. Endocrinology. 1990. PMID: 2351099
-
1,25-Dihydroxyvitamin D3 receptors: altered functional domains are associated with cellular resistance to vitamin D3.Adv Exp Med Biol. 1986;196:377-90. doi: 10.1007/978-1-4684-5101-6_25. Adv Exp Med Biol. 1986. PMID: 3012980 Review.
-
The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).Clin Endocrinol (Oxf). 1993 Aug;39(2):229-37. doi: 10.1111/j.1365-2265.1993.tb01779.x. Clin Endocrinol (Oxf). 1993. PMID: 8396512 Review.
Cited by
-
Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor.J Clin Invest. 1989 Jun;83(6):2093-101. doi: 10.1172/JCI114122. J Clin Invest. 1989. PMID: 2542381 Free PMC article.
-
Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.J Clin Invest. 1997 Jan 15;99(2):297-304. doi: 10.1172/JCI119158. J Clin Invest. 1997. PMID: 9005998 Free PMC article.
-
An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families.Proc Natl Acad Sci U S A. 1989 Dec;86(24):9783-7. doi: 10.1073/pnas.86.24.9783. Proc Natl Acad Sci U S A. 1989. PMID: 2557627 Free PMC article.
-
Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II.J Inherit Metab Dis. 1991;14(2):231-40. doi: 10.1007/BF01800596. J Inherit Metab Dis. 1991. PMID: 1653381
-
Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction.Eur J Pediatr. 1991 Jul;150(9):665-8. doi: 10.1007/BF02072630. Eur J Pediatr. 1991. PMID: 1655462
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical